Smith And Nephew Plc Quick Ratio (SNN) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Smith and Nephew Plc  (NYSE: SNN)

Smith And Nephew Plc's Quick Ratio

SNN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 0.21 below Smith And Nephew Plc average.

Within Medical Equipment & Supplies industry 110 other companies have achieved higher Quick Ratio than Smith And Nephew Plc in fourth quarter 2025. While Quick Ratio total ranking has improved so far during the Q4 2025 to 2085, from total ranking in the third quarter 2025 at 2766.

Explain Quick Ratio?
How much Cash & cash equivalents SNN´s has?
What are SNN´s Current Liabilities?




SNN Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change 4.25 % 4.18 % 4.18 % 4.18 % -20.05 %
Y / Y Cash & cash equivalent Change -12.25 % -12.25 % -12.25 % -12.25 % 94.93 %
Quick Ratio MRQ 0.21 0.36 0.36 0.36 0.25
SNN's Total Ranking # 2085 # 2766 # # #
Seq. Current Liabilities Change 73.79 % 0 % 0 % -40.02 % 73.68 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -12.25 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 534
Overall Market # 2085


Quick Ratio Statistics
High Average Low
0.43 0.27 0.01
(Dec 31 2024)   (Dec 31 2023)




Financial Statements
Smith And Nephew Plc's Current Liabilities $ 2,772 Millions Visit SNN's Balance sheet
Smith And Nephew Plc's Cash & cash equivalent $ 573 Millions Visit SNN's Balance sheet
Source of SNN's Sales Visit SNN's Sales by Geography


Cumulative Smith And Nephew Plc's Quick Ratio

SNN's Quick Ratio for the trailling 12 Months

SNN Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 4.21 % -6 % -14.77 % -22.16 % -28.47 %
Y / Y Cash & cash equivalent TTM Growth -12.25 % 3.4 % 46.48 % 140.23 % 501.84 %
Quick Ratio TTM 0.3 0.32 0.33 0.35 0.36
Total Ranking TTM # 2501 # 3822 # # #
Seq. Current Liabilities TTM Growth 1.52 % 0.87 % 0.87 % 0.88 % -8.42 %
Seq. Cash & cash equivalent TTM Growth -3.37 % -3.26 % -3.16 % -3.06 % 13.86 %


On the trailing twelve months basis Due to jump in Current Liabilities in the Q4 2025 to $2,772.00 millions, cumulative Quick Ratio decreased to 0.3 above the SNN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 125 other companies have achieved higher Quick Ratio than Smith And Nephew Plc. While Quick Ratio overall ranking has improved so far to 2501, from total ranking during the twelve months ending third quarter 2025 at 3822.

Explain Quick Ratio?
How much Cash & cash equivalents SNN´s has?
What are SNN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 126
Healthcare Sector # 587
Within the Market # 2501


trailing twelve months Quick Ratio Statistics
High Average Low
0.01 0.01 0.01
(Dec 31 2023)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Anteris Technologies Global Corp   0.57 $ 6.697  Millions$ 11.822  Millions
Solventum Corporation  0.56 $ 878.000  Millions$ 1,563.000  Millions
Align Technology inc   0.55 $ 1,094.908  Millions$ 2,005.558  Millions
U S Physical Therapy Inc  0.53 $ 35.570  Millions$ 66.654  Millions
Haemonetics Corporation  0.53 $ 306.763  Millions$ 578.113  Millions
Teleflex Incorporated  0.50 $ 378.564  Millions$ 762.026  Millions
Interpace Biosciences Inc   0.49 $ 2.505  Millions$ 5.103  Millions
Sanuwave Health Inc   0.45 $ 11.959  Millions$ 26.652  Millions
Orthofix Medical Inc   0.44 $ 82.025  Millions$ 186.329  Millions
Dexcom Inc   0.43 $ 917.700  Millions$ 2,129.800  Millions
Nuo Therapeutics Inc   0.42 $ 0.549  Millions$ 1.306  Millions
Iridex Corp  0.41 $ 6.028  Millions$ 14.608  Millions
Nuwellis Inc   0.40 $ 1.085  Millions$ 2.686  Millions
Picard Medical Inc   0.40 $ 7.451  Millions$ 18.695  Millions
Alcon inc   0.37 $ 1,547.000  Millions$ 4,162.000  Millions
Masimo Corp  0.37 $ 152.300  Millions$ 411.000  Millions
Boston Scientific Corporation  0.36 $ 1,965.000  Millions$ 5,439.000  Millions
Vsee Health Inc   0.35 $ 5.266  Millions$ 15.056  Millions
Star Equity Holdings Inc   0.34 $ 10.269  Millions$ 29.826  Millions
Lifeward ltd   0.34 $ 4.338  Millions$ 12.847  Millions
Adm Tronics Unlimited Inc   0.33 $ 0.383  Millions$ 1.149  Millions
Bioventus Inc   0.32 $ 51.238  Millions$ 160.380  Millions
Envoy Medical Inc   0.30 $ 3.739  Millions$ 12.487  Millions
Accuray Incorporated  0.30 $ 57.416  Millions$ 192.579  Millions
Heartsciences Inc   0.30 $ 1.098  Millions$ 3.703  Millions
Precision Optics Corporation Inc   0.29 $ 1.774  Millions$ 6.151  Millions
Strata Skin Sciences Inc  0.28 $ 7.912  Millions$ 28.019  Millions
Ufp Technologies Inc   0.27 $ 20.301  Millions$ 74.862  Millions
Retractable Technologies Inc  0.27 $ 2.589  Millions$ 9.598  Millions
Milestone Scientific Inc   0.27 $ 1.113  Millions$ 4.131  Millions

Date modified: 2026-09-08T15:11:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.